Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $147.9 million.

  • AtriCure's Cash & Current Investments rose 1345.0% to $147.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $147.9 million, marking a year-over-year increase of 1345.0%. This contributed to the annual value of $122.7 million for FY2024, which is 1060.86% down from last year.
  • As of Q3 2025, AtriCure's Cash & Current Investments stood at $147.9 million, which was up 1345.0% from $117.8 million recorded in Q2 2025.
  • In the past 5 years, AtriCure's Cash & Current Investments ranged from a high of $227.2 million in Q1 2021 and a low of $99.9 million during Q1 2025
  • For the 5-year period, AtriCure's Cash & Current Investments averaged around $130.1 million, with its median value being $122.6 million (2022).
  • Examining YoY changes over the last 5 years, AtriCure's Cash & Current Investments showed a top increase of 23150.71% in 2021 and a maximum decrease of 5123.62% in 2021.
  • Quarter analysis of 5 years shows AtriCure's Cash & Current Investments stood at $119.1 million in 2021, then increased by 1.7% to $121.1 million in 2022, then increased by 13.35% to $137.3 million in 2023, then dropped by 10.61% to $122.7 million in 2024, then rose by 20.49% to $147.9 million in 2025.
  • Its Cash & Current Investments stands at $147.9 million for Q3 2025, versus $117.8 million for Q2 2025 and $99.9 million for Q1 2025.